Genolution

Genolution Payables Turnover

The Payables Turnover Ratio of Genolution (225220.KQ) as of Oct 22, 2026 is 13.89. In the previous year, Payables Turnover Ratio was 11.71 — a change of 18.65% (higher).

Payables Turnover

13.89

YoY

18.65%

Last updated:

Payables Turnover Ratio of Genolution is 2025 13.89 . Payables Turnover Ratio of Genolution was 2024 11.71 . It decreases by 18.65% higher compared to the previous year.

The Genolution Payables Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Payables Turnover
Date
Payables Turnover
Jan 1, 2019
15.18 KRW
Jan 1, 2020
36.63 KRW
Jan 1, 2021
38.49 KRW
Jan 1, 2022
61.21 KRW
Jan 1, 2023
80.22 KRW
Jan 1, 2024
11.71 KRW
Jan 1, 2025
13.89 KRW
The Genolution Payables Turnover history
YEARPayables TurnoverYoY
13.89+18.65%
11.71-85.41%
80.22+31.07%
61.21+59.02%
38.49+5.06%
36.63+141.32%
15.18—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genolution Stock analysis

What does Genolution do? Genolution Inc develops automated nucleic acid extraction devices, nucleic acid extraction reagents, and molecular diagnostic products. The company also offers ribonucleic acid interference services. Its products are distributed domestically and internationally, serving customers in the biotechnology and healthcare sectors. The firm generates revenue through the sale of these products and services to research institutions, laboratories, and healthcare providers. The company's core offerings include nucleic acid extractors, reagents, and diagnostic products, which are used in molecular biology and medical diagnostics. Genolution Inc targets biotech firms, hospitals, and research facilities as key buyers of its technology. Its domestic market presence complements its international distribution channels. Genolution Inc's business model relies on selling its automated extraction devices and reagents to customers requiring efficient nucleic acid processing solutions. The company's molecular diagnostic products cater to healthcare applications, while its ribonucleic acid interference services support advanced research needs. Revenue streams are derived from both product sales and service contracts within the biotechnology industry. Genolution is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genolution stock

Payables Turnover Ratio of Genolution is 13.89 in 2025.

Payables Turnover Ratio of Genolution changed from 11.71 to 13.89, representing a 18.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Payables Turnover Ratio Genolution since 2006 – with annual values, charts, and detailed analysis.

Payables turnover measures how quickly a company pays its suppliers. Lower turnover may indicate better payment terms or cash flow management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Payables Turnover Ratio's Genolution with sector peers and the industry average to assess whether it is attractive.

To evaluate Payables Turnover Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Payables Turnover Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Genolution

All Key Metrics — Genolution